Tenax Therapeutics Stock Analysis

Tenax Stock Analysis Notes

About 48.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.21. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tenax Therapeutics recorded a loss per share of 13.05. The entity last dividend was issued on the 26th of February 2018. The firm had 1:80 split on the 3rd of January 2024. Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina. Tenax Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 8 people. To find out more about Tenax Therapeutics contact Christopher Giordano at (919) 855-2100 or learn more at https://www.tenaxthera.com.

Tenax Therapeutics Investment Alerts

Tenax Therapeutics Upcoming and Recent Events

Tenax Largest EPS Surprises

View All Earnings Estimates

Tenax Therapeutics Environmental, Social, and Governance (ESG) Scores

Tenax Stock Institutional Investors

Note, although Tenax Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Tenax Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.24 M.

Tenax Profitablity

Management Efficiency

Tenax Therapeutics has return on total asset (ROA) of (0.6609) % which means that it has lost $0.6609 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1379) %, meaning that it created substantial loss on money invested by shareholders. Tenax Therapeutics' management efficiency ratios could be used to measure how well Tenax Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.69 in 2024. Return On Capital Employed is likely to rise to -0.97 in 2024. At this time, Tenax Therapeutics' Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 2 M in 2024, whereas Non Current Assets Total are likely to drop 1,061 in 2024.

Technical Drivers

As of the 10th of December, Tenax Therapeutics has the Coefficient Of Variation of 453.39, risk adjusted performance of 0.1673, and Semi Deviation of 2.6. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tenax Therapeutics, as well as the relationship between them.

Tenax Therapeutics Price Movement Analysis

Tenax Therapeutics Insider Trading Activities

Tenax Therapeutics Outstanding Bonds

Tenax Therapeutics Predictive Daily Indicators

Tenax Therapeutics Corporate Filings

Tenax Therapeutics Forecast Models

Tenax Therapeutics' time-series forecasting models are one of many Tenax Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tenax Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Tenax Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tenax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tenax Therapeutics. By using and applying Tenax Stock analysis, traders can create a robust methodology for identifying Tenax entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tenax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tenax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Tenax Therapeutics stock analysis indicators help investors evaluate how Tenax Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tenax Therapeutics shares will generate the highest return on investment. By understating and applying Tenax Therapeutics stock analysis, traders can identify Tenax Therapeutics position entry and exit signals to maximize returns.

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.